Catapult Ventures (UK)

Sign up free to access full profile and submit your pitch.

About

Opus Ventures LLP is liquidating. The firm is a private equity and venture capital firm specializing in startups and early stage businesses. It prefers to invest in technology businesses in United Kingdom based companies. Ideally, it seeks to invest between £3 million ($4.81 million) and £5 million ($8.02 million) but will consider an investment of £0.5 million ($0.80 million). Opus Ventures LLP was founded in July 14, 2003 and is based in Matlock, United Kingdom.

Investment Criteria

Other investors that have backed the same portfolio companies as Catapult Ventures (UK). Expand any entry to see the shared portfolio companies.

• Mercia Fund Management Ltd.

  9 shared

  Shared portfolio companies

  • Anaxsys Technology Ltd
  • Biofortuna Limited
  • Intelligent Orthopaedics Ltd.
  • Kappler, Inc.
  • Manchester Imaging Limited
  • nanoTherics Limited
  • Oxford BioTherapeutics Ltd.
  • Promethean Particles Ltd.
  • Rinicare Ltd.
• GC Angels

  6 shared

  Shared portfolio companies

  • Biorelate Ltd.
  • Blueberry Therapeutics Ltd
  • eLucid mHealth Ltd.
  • Manchester Imaging Limited
  • Swabtech Ltd
  • Viscgo Limited
• Maven Capital Partners

  5 shared

  Shared portfolio companies

  • Acea Health Limited
  • Biorelate Ltd.
  • Blueberry Therapeutics Ltd
  • Cytox Limited
  • Healum Ltd.
• Midven

  4 shared

  Shared portfolio companies

  • Anaxsys Technology Ltd
  • Cytox Limited
  • Pencil Biosciences Limited
  • Promethean Particles Ltd.
• Alderley Park Ventures

  3 shared

  Shared portfolio companies

  • Maxwellia Ltd
  • metaLinear Ltd.
  • Pronec Limited
• Catapult Ventures

  3 shared

  Shared portfolio companies

  • Elroy Air, Inc.
  • Resonado, Inc.
  • Urban Sky Theory, Inc.
• Deepbridge Capital

  3 shared

  Shared portfolio companies

  • eLucid mHealth Ltd.
  • Pronec Limited
  • Viscgo Limited
• Octopus Ventures

  3 shared

  Shared portfolio companies

  • Intamac Systems Ltd.
  • Michelson Diagnostics Limited
  • Pencil Biosciences Limited
• Acceleris Limited, Investment Arm

  2 shared

  Shared portfolio companies

  • Apex Molecular Ltd
  • Infex Therapeutics Ltd.
• Foresight Group

  2 shared

  Shared portfolio companies

  • Biofortuna Limited
  • Promethean Particles Ltd.